nodes	percent_of_prediction	percent_of_DWPC	metapath
Vidarabine—Apprehension—Procarbazine—brain cancer	0.0589	0.0936	CcSEcCtD
Vidarabine—ADORA2A—ganglion—brain cancer	0.0399	0.123	CbGeAlD
Vidarabine—DPP4—blood vessel—brain cancer	0.0276	0.085	CbGeAlD
Vidarabine—Tonic-clonic seizures—Carmustine—brain cancer	0.0262	0.0417	CcSEcCtD
Vidarabine—Azacitidine—DNMT1—brain cancer	0.0188	0.413	CrCbGaD
Vidarabine—Decitabine—DNMT1—brain cancer	0.0184	0.403	CrCbGaD
Vidarabine—Intracranial pressure increased—Carmustine—brain cancer	0.0169	0.0269	CcSEcCtD
Vidarabine—Haemorrhage intracranial—Temozolomide—brain cancer	0.0166	0.0264	CcSEcCtD
Vidarabine—ADORA2A—telencephalon—brain cancer	0.0154	0.0473	CbGeAlD
Vidarabine—Grand mal convulsion—Carmustine—brain cancer	0.0148	0.0236	CcSEcCtD
Vidarabine—ADK—telencephalon—brain cancer	0.0138	0.0425	CbGeAlD
Vidarabine—ADORA2A—gonad—brain cancer	0.0128	0.0395	CbGeAlD
Vidarabine—ADK—gonad—brain cancer	0.0115	0.0355	CbGeAlD
Vidarabine—ADK—pituitary gland—brain cancer	0.0113	0.0346	CbGeAlD
Vidarabine—Throat tightness—Etoposide—brain cancer	0.0111	0.0177	CcSEcCtD
Vidarabine—ADK—medulla oblongata—brain cancer	0.0109	0.0334	CbGeAlD
Vidarabine—ADORA2A—spinal cord—brain cancer	0.0108	0.0332	CbGeAlD
Vidarabine—ADA—endocrine gland—brain cancer	0.0107	0.0328	CbGeAlD
Vidarabine—ADA—head—brain cancer	0.0105	0.0324	CbGeAlD
Vidarabine—Burning sensation—Carmustine—brain cancer	0.0102	0.0162	CcSEcCtD
Vidarabine—ADK—midbrain—brain cancer	0.00993	0.0305	CbGeAlD
Vidarabine—ADORA2A—endocrine gland—brain cancer	0.00971	0.0299	CbGeAlD
Vidarabine—ADK—spinal cord—brain cancer	0.00969	0.0298	CbGeAlD
Vidarabine—ADA—central nervous system—brain cancer	0.00962	0.0296	CbGeAlD
Vidarabine—ADORA2A—head—brain cancer	0.00959	0.0295	CbGeAlD
Vidarabine—Scotoma—Carmustine—brain cancer	0.0093	0.0148	CcSEcCtD
Vidarabine—Scotoma—Temozolomide—brain cancer	0.00899	0.0143	CcSEcCtD
Vidarabine—ADORA2A—central nervous system—brain cancer	0.00875	0.0269	CbGeAlD
Vidarabine—ADK—endocrine gland—brain cancer	0.00872	0.0268	CbGeAlD
Vidarabine—ADK—head—brain cancer	0.00861	0.0265	CbGeAlD
Vidarabine—ADORA2A—cerebellum—brain cancer	0.00855	0.0263	CbGeAlD
Vidarabine—DPP4—endocrine gland—brain cancer	0.00846	0.026	CbGeAlD
Vidarabine—Adenosine triphosphate—ALK—brain cancer	0.0084	0.184	CrCbGaD
Vidarabine—DPP4—head—brain cancer	0.00835	0.0257	CbGeAlD
Vidarabine—ADK—central nervous system—brain cancer	0.00786	0.0242	CbGeAlD
Vidarabine—ADK—cerebellum—brain cancer	0.00768	0.0236	CbGeAlD
Vidarabine—ADA—brain—brain cancer	0.00764	0.0235	CbGeAlD
Vidarabine—DPP4—central nervous system—brain cancer	0.00762	0.0234	CbGeAlD
Vidarabine—Injection site reaction—Carmustine—brain cancer	0.00702	0.0112	CcSEcCtD
Vidarabine—Respiratory failure—Temozolomide—brain cancer	0.00695	0.011	CcSEcCtD
Vidarabine—ADORA2A—brain—brain cancer	0.00695	0.0214	CbGeAlD
Vidarabine—Tingling sensation—Etoposide—brain cancer	0.0068	0.0108	CcSEcCtD
Vidarabine—Numbness—Etoposide—brain cancer	0.00659	0.0105	CcSEcCtD
Vidarabine—Pollakiuria—Procarbazine—brain cancer	0.00654	0.0104	CcSEcCtD
Vidarabine—Apnoea—Etoposide—brain cancer	0.00644	0.0102	CcSEcCtD
Vidarabine—Drowsiness—Procarbazine—brain cancer	0.00632	0.01	CcSEcCtD
Vidarabine—Sensory loss—Etoposide—brain cancer	0.00631	0.01	CcSEcCtD
Vidarabine—ADK—brain—brain cancer	0.00624	0.0192	CbGeAlD
Vidarabine—Pain—Carboplatin—brain cancer	0.0062	0.00986	CcSEcCtD
Vidarabine—Chest discomfort—Etoposide—brain cancer	0.00617	0.00981	CcSEcCtD
Vidarabine—Sweating—Procarbazine—brain cancer	0.00606	0.00962	CcSEcCtD
Vidarabine—DPP4—brain—brain cancer	0.00605	0.0186	CbGeAlD
Vidarabine—Nasal congestion—Temozolomide—brain cancer	0.00544	0.00865	CcSEcCtD
Vidarabine—Flushing—Procarbazine—brain cancer	0.00526	0.00836	CcSEcCtD
Vidarabine—Arrhythmia—Procarbazine—brain cancer	0.00507	0.00805	CcSEcCtD
Vidarabine—Drowsiness—Hydroxyurea—brain cancer	0.00489	0.00777	CcSEcCtD
Vidarabine—Affect lability—Temozolomide—brain cancer	0.00488	0.00775	CcSEcCtD
Vidarabine—Tension—Procarbazine—brain cancer	0.00484	0.0077	CcSEcCtD
Vidarabine—Nervousness—Procarbazine—brain cancer	0.00479	0.00762	CcSEcCtD
Vidarabine—Mood swings—Temozolomide—brain cancer	0.00469	0.00746	CcSEcCtD
Vidarabine—Tremor—Procarbazine—brain cancer	0.00462	0.00735	CcSEcCtD
Vidarabine—Syncope—Procarbazine—brain cancer	0.00443	0.00704	CcSEcCtD
Vidarabine—Loss of consciousness—Procarbazine—brain cancer	0.00434	0.0069	CcSEcCtD
Vidarabine—Cough—Procarbazine—brain cancer	0.00431	0.00685	CcSEcCtD
Vidarabine—Convulsion—Procarbazine—brain cancer	0.00428	0.0068	CcSEcCtD
Vidarabine—Hypertension—Procarbazine—brain cancer	0.00426	0.00677	CcSEcCtD
Vidarabine—Anxiety—Procarbazine—brain cancer	0.00419	0.00666	CcSEcCtD
Vidarabine—Dry mouth—Procarbazine—brain cancer	0.00411	0.00653	CcSEcCtD
Vidarabine—Cardiac failure—Etoposide—brain cancer	0.00406	0.00646	CcSEcCtD
Vidarabine—Vomiting—Lomustine—brain cancer	0.00403	0.00641	CcSEcCtD
Vidarabine—Shock—Procarbazine—brain cancer	0.00396	0.0063	CcSEcCtD
Vidarabine—Pollakiuria—Temozolomide—brain cancer	0.00396	0.00629	CcSEcCtD
Vidarabine—Tachycardia—Procarbazine—brain cancer	0.00393	0.00625	CcSEcCtD
Vidarabine—Hyperhidrosis—Procarbazine—brain cancer	0.00389	0.00619	CcSEcCtD
Vidarabine—Cardiac arrest—Etoposide—brain cancer	0.00377	0.00599	CcSEcCtD
Vidarabine—Nausea—Lomustine—brain cancer	0.00377	0.00599	CcSEcCtD
Vidarabine—Hypotension—Procarbazine—brain cancer	0.00376	0.00598	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00367	0.00583	CcSEcCtD
Vidarabine—Paraesthesia—Procarbazine—brain cancer	0.00362	0.00575	CcSEcCtD
Vidarabine—Somnolence—Procarbazine—brain cancer	0.00358	0.00569	CcSEcCtD
Vidarabine—Hypoaesthesia—Carmustine—brain cancer	0.00353	0.00561	CcSEcCtD
Vidarabine—Pain—Procarbazine—brain cancer	0.00345	0.00548	CcSEcCtD
Vidarabine—Hypoaesthesia—Temozolomide—brain cancer	0.00341	0.00542	CcSEcCtD
Vidarabine—Bronchospasm—Etoposide—brain cancer	0.00337	0.00536	CcSEcCtD
Vidarabine—Convulsion—Hydroxyurea—brain cancer	0.00331	0.00526	CcSEcCtD
Vidarabine—Flushing—Carmustine—brain cancer	0.00329	0.00523	CcSEcCtD
Vidarabine—Discomfort—Hydroxyurea—brain cancer	0.00321	0.00511	CcSEcCtD
Vidarabine—Urticaria—Procarbazine—brain cancer	0.0032	0.00509	CcSEcCtD
Vidarabine—Tinnitus—Temozolomide—brain cancer	0.0032	0.00508	CcSEcCtD
Vidarabine—Cardiac disorder—Temozolomide—brain cancer	0.00318	0.00506	CcSEcCtD
Vidarabine—Flushing—Temozolomide—brain cancer	0.00318	0.00506	CcSEcCtD
Vidarabine—Arrhythmia—Carmustine—brain cancer	0.00317	0.00504	CcSEcCtD
Vidarabine—Mediastinal disorder—Temozolomide—brain cancer	0.00309	0.00491	CcSEcCtD
Vidarabine—Acute coronary syndrome—Etoposide—brain cancer	0.00301	0.00479	CcSEcCtD
Vidarabine—Myocardial infarction—Etoposide—brain cancer	0.003	0.00476	CcSEcCtD
Vidarabine—Back pain—Carmustine—brain cancer	0.00299	0.00475	CcSEcCtD
Vidarabine—Hypersensitivity—Procarbazine—brain cancer	0.00297	0.00472	CcSEcCtD
Vidarabine—Dysgeusia—Temozolomide—brain cancer	0.00292	0.00465	CcSEcCtD
Vidarabine—Vision blurred—Carmustine—brain cancer	0.00291	0.00463	CcSEcCtD
Vidarabine—Tremor—Carmustine—brain cancer	0.00289	0.0046	CcSEcCtD
Vidarabine—Asthenia—Procarbazine—brain cancer	0.00289	0.00459	CcSEcCtD
Vidarabine—Back pain—Temozolomide—brain cancer	0.00289	0.00459	CcSEcCtD
Vidarabine—Agitation—Carmustine—brain cancer	0.00284	0.00451	CcSEcCtD
Vidarabine—Vision blurred—Temozolomide—brain cancer	0.00281	0.00447	CcSEcCtD
Vidarabine—Tremor—Temozolomide—brain cancer	0.0028	0.00444	CcSEcCtD
Vidarabine—Dyspnoea—Hydroxyurea—brain cancer	0.00278	0.00442	CcSEcCtD
Vidarabine—Somnolence—Hydroxyurea—brain cancer	0.00277	0.00441	CcSEcCtD
Vidarabine—Agitation—Temozolomide—brain cancer	0.00274	0.00436	CcSEcCtD
Vidarabine—Hypoaesthesia—Etoposide—brain cancer	0.00273	0.00434	CcSEcCtD
Vidarabine—Angioedema—Temozolomide—brain cancer	0.00273	0.00433	CcSEcCtD
Vidarabine—Convulsion—Carmustine—brain cancer	0.00268	0.00425	CcSEcCtD
Vidarabine—Hypertension—Carmustine—brain cancer	0.00267	0.00424	CcSEcCtD
Vidarabine—Pain—Hydroxyurea—brain cancer	0.00267	0.00424	CcSEcCtD
Vidarabine—Dizziness—Procarbazine—brain cancer	0.00266	0.00423	CcSEcCtD
Vidarabine—Palpitations—Temozolomide—brain cancer	0.00264	0.00419	CcSEcCtD
Vidarabine—Chest pain—Carmustine—brain cancer	0.00263	0.00418	CcSEcCtD
Vidarabine—Anxiety—Carmustine—brain cancer	0.00262	0.00416	CcSEcCtD
Vidarabine—Cough—Temozolomide—brain cancer	0.0026	0.00414	CcSEcCtD
Vidarabine—Convulsion—Temozolomide—brain cancer	0.00259	0.00411	CcSEcCtD
Vidarabine—Hypertension—Temozolomide—brain cancer	0.00258	0.0041	CcSEcCtD
Vidarabine—Vomiting—Procarbazine—brain cancer	0.00256	0.00407	CcSEcCtD
Vidarabine—Flushing—Etoposide—brain cancer	0.00255	0.00405	CcSEcCtD
Vidarabine—Cardiac disorder—Etoposide—brain cancer	0.00255	0.00405	CcSEcCtD
Vidarabine—Rash—Procarbazine—brain cancer	0.00254	0.00404	CcSEcCtD
Vidarabine—Dermatitis—Procarbazine—brain cancer	0.00254	0.00403	CcSEcCtD
Vidarabine—Anxiety—Temozolomide—brain cancer	0.00253	0.00402	CcSEcCtD
Vidarabine—Headache—Procarbazine—brain cancer	0.00252	0.00401	CcSEcCtD
Vidarabine—Discomfort—Temozolomide—brain cancer	0.00251	0.00399	CcSEcCtD
Vidarabine—Dry mouth—Temozolomide—brain cancer	0.00248	0.00395	CcSEcCtD
Vidarabine—Mediastinal disorder—Etoposide—brain cancer	0.00247	0.00393	CcSEcCtD
Vidarabine—Tachycardia—Carmustine—brain cancer	0.00246	0.00391	CcSEcCtD
Vidarabine—Anaphylactic shock—Temozolomide—brain cancer	0.00244	0.00387	CcSEcCtD
Vidarabine—Nausea—Procarbazine—brain cancer	0.00239	0.0038	CcSEcCtD
Vidarabine—Hypotension—Carmustine—brain cancer	0.00236	0.00374	CcSEcCtD
Vidarabine—Hyperhidrosis—Temozolomide—brain cancer	0.00235	0.00374	CcSEcCtD
Vidarabine—Dysgeusia—Etoposide—brain cancer	0.00234	0.00372	CcSEcCtD
Vidarabine—Back pain—Etoposide—brain cancer	0.00231	0.00367	CcSEcCtD
Vidarabine—Hypersensitivity—Hydroxyurea—brain cancer	0.0023	0.00365	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Carmustine—brain cancer	0.0023	0.00365	CcSEcCtD
Vidarabine—Paraesthesia—Carmustine—brain cancer	0.00226	0.0036	CcSEcCtD
Vidarabine—Dyspnoea—Carmustine—brain cancer	0.00225	0.00357	CcSEcCtD
Vidarabine—Somnolence—Carmustine—brain cancer	0.00224	0.00356	CcSEcCtD
Vidarabine—Asthenia—Hydroxyurea—brain cancer	0.00224	0.00356	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Temozolomide—brain cancer	0.00222	0.00353	CcSEcCtD
Vidarabine—Paraesthesia—Temozolomide—brain cancer	0.00219	0.00348	CcSEcCtD
Vidarabine—Dyspnoea—Temozolomide—brain cancer	0.00217	0.00345	CcSEcCtD
Vidarabine—Somnolence—Temozolomide—brain cancer	0.00217	0.00344	CcSEcCtD
Vidarabine—Pain—Carmustine—brain cancer	0.00216	0.00343	CcSEcCtD
Vidarabine—Loss of consciousness—Etoposide—brain cancer	0.0021	0.00334	CcSEcCtD
Vidarabine—Cough—Etoposide—brain cancer	0.00208	0.00331	CcSEcCtD
Vidarabine—Pain—Temozolomide—brain cancer	0.00208	0.00331	CcSEcCtD
Vidarabine—Convulsion—Etoposide—brain cancer	0.00207	0.00329	CcSEcCtD
Vidarabine—Hypertension—Etoposide—brain cancer	0.00206	0.00328	CcSEcCtD
Vidarabine—Dizziness—Hydroxyurea—brain cancer	0.00206	0.00328	CcSEcCtD
Vidarabine—Chest pain—Etoposide—brain cancer	0.00203	0.00323	CcSEcCtD
Vidarabine—Discomfort—Etoposide—brain cancer	0.00201	0.00319	CcSEcCtD
Vidarabine—Vomiting—Hydroxyurea—brain cancer	0.00198	0.00315	CcSEcCtD
Vidarabine—Rash—Hydroxyurea—brain cancer	0.00197	0.00312	CcSEcCtD
Vidarabine—Dermatitis—Hydroxyurea—brain cancer	0.00196	0.00312	CcSEcCtD
Vidarabine—Headache—Hydroxyurea—brain cancer	0.00195	0.0031	CcSEcCtD
Vidarabine—Anaphylactic shock—Etoposide—brain cancer	0.00195	0.0031	CcSEcCtD
Vidarabine—Urticaria—Temozolomide—brain cancer	0.00193	0.00308	CcSEcCtD
Vidarabine—Tachycardia—Etoposide—brain cancer	0.0019	0.00302	CcSEcCtD
Vidarabine—Hyperhidrosis—Etoposide—brain cancer	0.00188	0.00299	CcSEcCtD
Vidarabine—Hypersensitivity—Carmustine—brain cancer	0.00186	0.00295	CcSEcCtD
Vidarabine—Nausea—Hydroxyurea—brain cancer	0.00185	0.00294	CcSEcCtD
Vidarabine—Hypotension—Etoposide—brain cancer	0.00182	0.00289	CcSEcCtD
Vidarabine—Asthenia—Carmustine—brain cancer	0.00181	0.00287	CcSEcCtD
Vidarabine—Hypersensitivity—Temozolomide—brain cancer	0.00179	0.00285	CcSEcCtD
Vidarabine—Paraesthesia—Etoposide—brain cancer	0.00175	0.00278	CcSEcCtD
Vidarabine—Asthenia—Temozolomide—brain cancer	0.00175	0.00278	CcSEcCtD
Vidarabine—Dyspnoea—Etoposide—brain cancer	0.00174	0.00276	CcSEcCtD
Vidarabine—Somnolence—Etoposide—brain cancer	0.00173	0.00275	CcSEcCtD
Vidarabine—Dizziness—Carmustine—brain cancer	0.00167	0.00265	CcSEcCtD
Vidarabine—Pain—Etoposide—brain cancer	0.00167	0.00265	CcSEcCtD
Vidarabine—Dizziness—Temozolomide—brain cancer	0.00161	0.00256	CcSEcCtD
Vidarabine—Vomiting—Carmustine—brain cancer	0.0016	0.00255	CcSEcCtD
Vidarabine—Rash—Carmustine—brain cancer	0.00159	0.00253	CcSEcCtD
Vidarabine—Dermatitis—Carmustine—brain cancer	0.00159	0.00252	CcSEcCtD
Vidarabine—Headache—Carmustine—brain cancer	0.00158	0.00251	CcSEcCtD
Vidarabine—Vomiting—Temozolomide—brain cancer	0.00155	0.00246	CcSEcCtD
Vidarabine—Urticaria—Etoposide—brain cancer	0.00155	0.00246	CcSEcCtD
Vidarabine—Rash—Temozolomide—brain cancer	0.00154	0.00244	CcSEcCtD
Vidarabine—Dermatitis—Temozolomide—brain cancer	0.00153	0.00244	CcSEcCtD
Vidarabine—Headache—Temozolomide—brain cancer	0.00153	0.00243	CcSEcCtD
Vidarabine—Nausea—Carmustine—brain cancer	0.0015	0.00238	CcSEcCtD
Vidarabine—Nausea—Temozolomide—brain cancer	0.00145	0.0023	CcSEcCtD
Vidarabine—Hypersensitivity—Etoposide—brain cancer	0.00144	0.00228	CcSEcCtD
Vidarabine—Asthenia—Etoposide—brain cancer	0.0014	0.00222	CcSEcCtD
Vidarabine—Dizziness—Etoposide—brain cancer	0.00129	0.00205	CcSEcCtD
Vidarabine—Vomiting—Etoposide—brain cancer	0.00124	0.00197	CcSEcCtD
Vidarabine—Rash—Etoposide—brain cancer	0.00123	0.00195	CcSEcCtD
Vidarabine—Dermatitis—Etoposide—brain cancer	0.00123	0.00195	CcSEcCtD
Vidarabine—Headache—Etoposide—brain cancer	0.00122	0.00194	CcSEcCtD
Vidarabine—Nausea—Etoposide—brain cancer	0.00116	0.00184	CcSEcCtD
